Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: The PERCRO-DOC survey

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 598-603

  Reiner, Željko ^a   Sonicki, Zdenko ^b   Tedeschi Reiner, Eugenia ^c  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Coronary heart disease; Family practice; Guidelines; Hypercholesterolemia, Hypertension; Prevention; Risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; AWARENESS; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; HEALTH CARE PLANNING; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KNOWLEDGE; MEDICAL PRACTICE; MEDICAL SPECIALIST; PATIENT EDUCATION; PERCEPTION; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SOCIOECONOMICS; WORK EXPERIENCE;

ATTITUDE OF HEALTH PERSONNEL; CARDIOLOGY; CARDIOVASCULAR DISEASES; CLINICAL COMPETENCE; CROATIA; DATA COLLECTION; DIABETES COMPLICATIONS; GENERAL PRACTITIONERS; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; INTERNAL MEDICINE; PHYSICIANS, PRIMARY CARE; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RISK FACTORS;

EID: 78649749546     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.09.014     Document Type: Article

References (30)

1. Allender S., Scarborough P., Peto V., et al. European cardiovascular disease statistics-2008 edition 2008, European Heart Network, Brussels.
2. Reiner Ž., Tedeschi-Reiner E. Atherosclerosis-a paradox of Eastern European countries. Atherosclerosis 2006, 7/3(Suppl.):461.
3. Levi F., Chatenoud L., Bertuccio P., et al. Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil 2009, 16:333-350.
4. Graham I., Atar D., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Eur J Cardiovasc Prev Rehabil 2007, 14(Suppl. 2):S1-S113.
5. Reiner Ž. Cardiovascular prevention under the burden of cardiovascular disease: what should be done and what could be done. Fundam Clin Pharmacol 2008, 22(Suppl. 2):1-3.
6. Reiner Ž, Muačević-Katanec D. Impact of treating dyslipidemia on cardiovascular events. In: Mancini M, Ordovas JM, Riccardi G, Rubba P, Strazzullo P., editors. Cardiovascular diseases: nutritional and metabolic bases. Willey Blackwell Publishers; in press.
7. Pyorala K., De Backer G., Graham I., Poole-Wilson P., Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology. European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis 1994, 110:121-161.
8. Wood D., De Backer G., Faergeman O., et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Second joint task force of European and other societies on coronary prevention. Eur Heart J 1998, 19:1434-1503.
9. De Backer G., Ambrosioni E., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2003, 10(Suppl. 1):S1-S78.
10. Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report. Circulation 2002, 106:3143-3421.
11. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
12. Reiner Z., Mihatov Š., Miličić D., Bergovec M., Planinc D. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study). Eur J Cardiovasc Prev Rehabil 2006, 13:636-654.
13. Kotseva K., Wood D., De Backer G., et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009, 16:121-137.
14. Kotseva K., Wood D., De Backer G., et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009, 373:929-940.
15. Reiner Z., Amouyel P., De Backer G., et al. Treatment of dyslipidaemia in coronary patients in Europe: improving but still inadequate. Eur Heart J 2008, 29(Abstract Suppl.):761-762.
16. Croatian health service yearbook for 2007 2008, Croatian National Institute of Public Health, Zagreb, p. 102-8.
17. Hobbs F.D., Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 2002, 19:596-604.
18. Heidrich J., Behrens T., Raspe F., Keil U. Knowledge and perception of guidelines and secondary prevention of coronary heart disease among general practitioners and internists. Results from a physician survey in Germany. Eur J Cardiovasc Prev Rehabil 2005, 12:521-529.
19. Graham I.M., Stewart M., Hertog MG Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology. Eur J Cardiovasc Prev Rehabil 2006, 13:839-845. Cardiovascular Round Table Task Force.
20. Mosca L., Linfante A.H., Benjamin E.J., et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005, 111:499-510.
21. Doroodchi H., Abdolrasulnia M., Foster J.A., et al. Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events. BMC Fam Pract 2008, 9:42.
22. Go A.S., Rao R.K., Dauterman K.W., Massie B.M. A systematic review of the effects of physician speciality on the treatment of coronary disease and heart failure in the United States. Am J Med 2000, 108:216-226.
23. 3I). Diabetes Vasc Dis Res 2008, 4:319-335.
24. Fruchart J.-C., Sacks F., Hermans M.P., et al. The residual risk reduction initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008, 102:1K-34K.
25. Cooney M.T., Dudina A., De Bacquer D., et al. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis 2009, 206:611-616.
26. Reiner Ž. Combined therapy in the treatment of dyslipidemia. Fundam Clin Pharmacol 2010, 24:19-28.
27. Reiner Ž, Sonicki Z., Tedeschi-Reiner E. Public perceptions of cardiovascular risk factors: the PERCRO survey. Prev Med 2010, 10.1016/j.ypmed.2010.09.015.
28. Bergman Marković B., Kranjčević K., Reiner Z., Milaković Blažeković S., Stojanović Špehar S. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service. Croat Med J 2005, 46:984-989.
29. Reiner Z. How to improve cardiovascular diseases prevention in Europe?. Nutr Metab Cardiovasc Dis 2009, 19:451-454.
30. Graham I., Atar D., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice:executive summary. Eur Heart J 2007, 28:2375-2414.